Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA

Mingwei Chen, Xuedong Wei, Xiu Shi, Le Lu, Guangbo Zhang, Yuhua Huang and Jianquan Hou
Cancer Biology & Medicine May 2021, 18 (2) 587-603; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0209
Mingwei Chen
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuedong Wei
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu Shi
2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Le Lu
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guangbo Zhang
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
3Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Jiangsu Key Laboratory of Gastrointestinal Tumor Immunology, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhua Huang
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianquan Hou
1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jianquan Hou
  • For correspondence: xf_192{at}163.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 18 no. 2 587-603
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2020.0209

Published By 
Cancer Biology & Medicine
History 
  • Received May 4, 2020
  • Accepted August 21, 2020
  • Published online May 1, 2021.

Copyright & Usage 
Copyright: © 2021, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Mingwei Chen1,
  2. Xuedong Wei1,
  3. Xiu Shi2,
  4. Le Lu1,
  5. Guangbo Zhang1,3,
  6. Yuhua Huang1 and
  7. Jianquan Hou1⇑
  1. 1Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  2. 2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
  3. 3Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Jiangsu Key Laboratory of Gastrointestinal Tumor Immunology, Suzhou 215006, China
  1. Correspondence to: Jianquan Hou, E-mail: xf_192{at}163.com
View Full Text

Cited By...

  • 25 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 18 (2)
Cancer Biology & Medicine
Vol. 18, Issue 2
1 May 2021
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
Mingwei Chen, Xuedong Wei, Xiu Shi, Le Lu, Guangbo Zhang, Yuhua Huang, Jianquan Hou
Cancer Biology & Medicine May 2021, 18 (2) 587-603; DOI: 10.20892/j.issn.2095-3941.2020.0209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
Mingwei Chen, Xuedong Wei, Xiu Shi, Le Lu, Guangbo Zhang, Yuhua Huang, Jianquan Hou
Cancer Biology & Medicine May 2021, 18 (2) 587-603; DOI: 10.20892/j.issn.2095-3941.2020.0209
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Conclusions
    • Supporting Information
    • Grant support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
  • Google Scholar

More in this TOC Section

  • Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial
  • Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
  • FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells
Show more Original Article

Similar Articles

Keywords

  • HIF1A-AS2
  • SOX4
  • miR-30a-5p
  • kidney carcinoma
  • CeRNA

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire